FDA inspection
Reliance Life Sciences Private Limited: FDA inspection ending Feb 27, 2026
FDA inspection 1311632 · Official Action Indicated (OAI) · Navi Mumbai
Key facts
| Inspection ID | 1311632 |
|---|---|
| Firm | Reliance Life Sciences Private Limited |
| FEI number | 3009510975 |
| Address | Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road |
| City | Navi Mumbai |
| Country | India |
| Fiscal year | 2026 |
| Inspection end date | Feb 27, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 730801 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data